TAM
LGND icon

Trillium Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Trillium Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,626
Closed -$572K – 237
2020
Q3 		$572K Sell
9,626
-4,397
-31% -$300K 0.02% 186
2020
Q2 		$978K Sell
14,023
-295
-2% -$18.7K 0.04% 174
2020
Q1 		$650K Sell
14,318
-40
-0.3% -$2.27K 0.03% 180
2019
Q4 		$934K Sell
14,358
-792
-5% -$52.9K 0.04% 185
2019
Q3 		$941K Buy
15,150
+154
+1% +$9.67K 0.04% 188
2019
Q2 		$1.07M Buy
14,996
+1,779
+13% +$131K 0.05% 179
2019
Q1 		$1.04M Buy
13,217
+6,186
+88% +$469K 0.05% 180
2018
Q4 		$595K Buy
7,031
+274
+4% +$29.2K 0.03% 191
2018
Q3 		$1.16M Sell
6,757
-248
-4% -$37.4K 0.06% 183
2018
Q2 		$905K Sell
7,005
-39
-0.6% -$4.35K 0.05% 186
2018
Q1 		$726K Sell
7,044
-269
-4% -$26.6K 0.04% 189
2017
Q4 		$625K Sell
7,313
-13
-0.2% -$1.13K 0.03% 186
2017
Q3 		$622K Buy
7,326
+95
+1% +$7.52K 0.04% 184
2017
Q2 		$548K Buy
7,231
+324
+5% +$22.7K 0.03% 188
2017
Q1 		$456K Buy
6,907
+609
+10% +$40.1K 0.03% 186
2016
Q4 		$399K Buy
6,298
+561
+10% +$35.4K 0.03% 189
2016
Q3 		$365K Buy
+5,737
New +$421K 0.02% 189

Other funds holding LGND

William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Trillium Asset Management's LGND Position: Q4 2020 in Review

Trillium Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q4 2020, closing a stake of 9,626 shares — an estimated $572K sold.

Trillium Asset Management first reported a position in LGND in Q3 2016 and held it in 17 quarters. The position peaked at $1.16M in Q3 2018. 242 funds tracked by Wall St. Rank hold LGND as of Q4 2020.

  • Trillium Asset Management reported no remaining Ligand Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Trillium Asset Management sold 9,626 Ligand Pharmaceuticals shares in Q4 2020, an estimated $572K.
  • Trillium Asset Management first reported a position in Ligand Pharmaceuticals in Q3 2016 and held it in 17 quarters.
  • Trillium Asset Management's Ligand Pharmaceuticals position peaked at $1.16M in Q3 2018.
  • 242 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2020.

Based on Trillium Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.